A recent study claims to be the first to have established the association of oral infection in males with sexual behaviour, not just on the basis of their reported sexual behaviour, but through the collection of data from their partners.
15 December 2014 | BMJ Blogs
HIV-infected adults are at a higher risk for developing heart attacks, kidney failure and cancer. But, contrary to what many had believed, the researchers say these illnesses are occurring at similar ages as adults who are not infected with HIV.
10 December 2014 | Science Daily
Sexual behavior of teenage girls does not appear to be impacted by the human papilloma virus (HPV) vaccine, according to Queen's University, Canada researchers Drs. Leah Smith and Linda Lévesque.
09 December 2014 | Eurekalert
HIV-positive patients with lymphoma were previously excluded from receiving autologous blood stem cell transplants as treatment, because of concern that these patients’ compromised immune systems would have a higher risk of infection and poor graft function due to their need for HIV medications. Results from the clinical trial, presented at the American Society of Hematology (ASH) meetings, show the concern of additional risk is unfounded.
08 December 2014 | Business Wire (press release)
Although prostate cancer can be successfully treated in many men, when the disease metastasizes to the bone, it is eventually lethal. The receptor CCR5, targeted by HIV drugs, is also key in driving prostate cancer metastases, suggesting that blocking this molecule could slow prostate cancer spread.
02 December 2014 | Science Daily
The HPV vaccine should be given to men who have sex with men, according to the government's experts. It is is already given to schoolgirls in the UK, but there have been calls for the vaccination programme to be extended. The Joint Committee on Vaccination and Immunisation now recommends offering the jab at sexual health clinics to men who have sex with men, aged between 16 and 40.
12 November 2014 | BBC News
Study participants who reported tobacco use or had higher levels of biomarkers of tobacco exposure had a higher prevalence of the sexually transmitted infection, oral human papillomavirus type 16, according to a study in the Oct. 8 JAMA, a theme issue on infectious disease. HPV-16 is the most common cancer-causing variety of HPV.
08 October 2014 | Eurekalert
A recently published study claims to provide the first whole population analysis of the impact on genital warts of a national HPV vaccination programme – and this may be the best predictor of the longer-term, and more important, cancer prevention benefits to be seen in future years. The findings show a decline of 89.9% in admissions involving warts from 2006/7 to 2010/11 for girls aged 12-17 yrs, a decline of 72.7% for women aged 18-26, and a decline of 38% for men aged 18-14 (the indirect effect of female vaccination).
01 October 2014 | BMJ Group blogs
Six leading parliamentarians have today declared their support for vaccinating boys against HPV infection. Their joint statement said: "In our view, all adolescent boys should be offered the vaccine."
09 September 2014 | HPV Action
As effective treatments for HIV become more widely available in low-income and middle-income countries, there's an urgent need to assess and manage health risks in the growing number of people living with HIV. An update on non-communicable diseases among HIV-positive populations in low-income and middle-income countries appears as a supplement to in JAIDS: Journal of Acquired Immune Deficiency Syndromes. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
14 August 2014 | Eurekalert Medicine & Health